Ukraine (UA)

Oxidative Burst-Dependent NETosis Is Implicated in the Resolution of Necrosis-Associated Sterile Inflammation (2016) Biermann MHC, Podolska M, Knopf J, Reinwald C, Weidner D, Maueröder C, Hahn J, et al. Journal article Enhancement of up-conversion luminescence in Er,Ce doped Y3-xYbxAG single crystalline films (2016) Zorenko Y, Gorbenko V, Zorenko T, Paprocki K, Osvet A, Batentschuk M, Brabec C, Fedorov A Journal article, Original article The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation. (2015) Fickentscher C, Magorivska I, Janko C, Biermann M, Bilyy R, Nalli C, Tincani A, et al. Journal article Upper Paleolithic of Middle Dniester: Doroshivtsi III site (2015) Larissa K, Usik V, Haesearts P, Ridush B, Uthmeier T, Hauck T Journal article, Original article Compositeelectrocatalysts containing valve metal oxides: Synthesis, physico-chemical properties and electrocatalytic activity (2015) Velichenko AB, Kasian OI, Knysh VA, Luk'yanenko TV Journal article Optimal Control in Matrix-Valued Coefficients for Nonlinear Monotone Problems: Optimality Conditions I (2015) Kogut PI, Kupenko OP, Leugering G Journal article Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus (2015) Sjowall C, Zapf J, Von Loehneysen S, Magorivska I, Biermann M, Janko C, Winkler S, et al. Journal article GHSR DNA hypermethylation is a common epigenetic alteration of high diagnostic value in a broad spectrum of cancers (2015) Moskalev EA, Jandaghi P, Fallah M, Manoochehri M, Botla SK, Kolychev OV, Nikitin EA, et al. Journal article Desialylation of dying cells with catalytically active antibodies possessing sialidase activity facilitate their clearance by human macrophages (2015) Tomin A, Dumych T, Tolstyak Y, Kril I, Mahorivska I, Bila E, Stoika R, et al. Journal article MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial (2015) Behrens F, Tak PP, Ostergaard M, Stoilov R, Wiland P, Huizinga TW, Berenfus VY, et al. Journal article